SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008252
Filing Date
2019-05-10
Accepted
2019-05-10 14:46:00
Documents
36
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_bioxytran.htm 10-Q 184025
2 CERTIFICATION f10q0319ex31-1_bioxytran.htm EX-31.1 10944
3 CERTIFICATION f10q0319ex32-1_bioxytran.htm EX-32.1 4926
  Complete submission text file 0001213900-19-008252.txt   1288272

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bixt-20190331.xml EX-101.INS 141725
5 XBRL SCHEMA FILE bixt-20190331.xsd EX-101.SCH 21723
6 XBRL CALCULATION FILE bixt-20190331_cal.xml EX-101.CAL 23820
7 XBRL DEFINITION FILE bixt-20190331_def.xml EX-101.DEF 59716
8 XBRL LABEL FILE bixt-20190331_lab.xml EX-101.LAB 139358
9 XBRL PRESENTATION FILE bixt-20190331_pre.xml EX-101.PRE 112368
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 19814368
SIC: 2834 Pharmaceutical Preparations